ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/25 | 1,938 | 2,022 | 1,926 | 1,989 | +43 | +2.2% | 2,905,500 |
2023/09/22 | 1,882 | 1,979 | 1,876 | 1,946 | +37 | +1.9% | 3,857,200 |
2023/09/21 | 2,150 | 2,160 | 1,890 | 1,909 | -267 | -12.3% | 6,169,900 |
2023/09/20 | 2,140 | 2,264 | 2,135 | 2,176 | +44 | +2.1% | 3,998,700 |
2023/09/19 | 2,148 | 2,165 | 2,076 | 2,132 | -27 | -1.3% | 2,590,500 |
2023/09/15 | 2,203 | 2,252 | 2,116 | 2,159 | -34 | -1.6% | 3,157,000 |
2023/09/14 | 2,135 | 2,208 | 2,097 | 2,193 | +68 | +3.2% | 3,448,100 |
2023/09/13 | 2,198 | 2,242 | 2,125 | 2,125 | -79 | -3.6% | 4,496,400 |
2023/09/12 | 2,255 | 2,358 | 2,201 | 2,204 | -38 | -1.7% | 9,358,800 |
2023/09/11 | 2,140 | 2,268 | 2,110 | 2,242 | +102 | +4.8% | 5,055,400 |
2023/09/08 | 2,100 | 2,179 | 2,091 | 2,140 | +31 | +1.5% | 3,909,700 |
2023/09/07 | 2,186 | 2,206 | 2,071 | 2,109 | -127 | -5.7% | 6,223,600 |
2023/09/06 | 2,246 | 2,285 | 2,195 | 2,236 | -10 | -0.4% | 4,963,100 |
2023/09/05 | 2,189 | 2,318 | 2,189 | 2,246 | +60 | +2.7% | 8,793,900 |
2023/09/04 | 2,111 | 2,220 | 2,085 | 2,186 | +54 | +2.5% | 8,708,100 |
2023/09/01 | 2,200 | 2,220 | 2,012 | 2,132 | -8 | -0.4% | 12,809,100 |
2023/08/31 | 2,354 | 2,382 | 2,111 | 2,140 | -258 | -10.8% | 16,190,300 |
2023/08/30 | 2,259 | 2,408 | 2,235 | 2,398 | +102 | +4.4% | 11,150,300 |
2023/08/29 | 2,288 | 2,346 | 2,203 | 2,296 | +31 | +1.4% | 11,930,300 |
2023/08/28 | 2,095 | 2,295 | 2,090 | 2,265 | +170 | +8.1% | 12,027,500 |
2023/08/25 | 2,039 | 2,128 | 1,957 | 2,095 | +25 | +1.2% | 9,971,900 |
2023/08/24 | 2,150 | 2,271 | 1,897 | 2,070 | -99 | -4.6% | 23,692,000 |
2023/08/23 | 2,070 | 2,193 | 2,016 | 2,169 | +83 | +4% | 10,579,600 |
2023/08/22 | 1,970 | 2,096 | 1,941 | 2,086 | +116 | +5.9% | 12,291,300 |
2023/08/21 | 1,812 | 2,041 | 1,812 | 1,970 | +165 | +9.1% | 11,067,800 |
2023/08/18 | 1,751 | 1,805 | 1,666 | 1,805 | +4 | +0.2% | 5,448,900 |
2023/08/17 | 1,711 | 1,822 | 1,688 | 1,801 | +88 | +5.1% | 5,403,000 |
2023/08/16 | 1,590 | 1,748 | 1,570 | 1,713 | +134 | +8.5% | 6,153,900 |
2023/08/15 | 1,398 | 1,598 | 1,385 | 1,579 | +211 | +15.4% | 4,646,000 |
2023/08/14 | 1,367 | 1,385 | 1,349 | 1,368 | +25 | +1.9% | 765,500 |
2023/08/10 | 1,333 | 1,350 | 1,319 | 1,343 | +2 | +0.1% | 688,700 |
2023/08/09 | 1,325 | 1,348 | 1,308 | 1,341 | +14 | +1.1% | 636,200 |
2023/08/08 | 1,321 | 1,341 | 1,308 | 1,327 | +2 | +0.2% | 656,100 |
2023/08/07 | 1,343 | 1,375 | 1,316 | 1,325 | -21 | -1.6% | 1,754,600 |
2023/08/04 | 1,303 | 1,366 | 1,302 | 1,346 | +13 | +1% | 2,247,700 |
2023/08/03 | 1,241 | 1,441 | 1,235 | 1,333 | +78 | +6.2% | 4,639,900 |
2023/08/02 | 1,281 | 1,294 | 1,248 | 1,255 | -44 | -3.4% | 841,800 |
2023/08/01 | 1,291 | 1,314 | 1,273 | 1,299 | +2 | +0.2% | 900,900 |
2023/07/31 | 1,279 | 1,312 | 1,251 | 1,297 | +78 | +6.4% | 1,615,000 |
2023/07/28 | 1,173 | 1,221 | 1,167 | 1,219 | +37 | +3.1% | 794,900 |
2023/07/27 | 1,175 | 1,189 | 1,169 | 1,182 | +1 | +0.1% | 367,700 |
2023/07/26 | 1,180 | 1,199 | 1,169 | 1,181 | -11 | -0.9% | 446,500 |
2023/07/25 | 1,190 | 1,193 | 1,166 | 1,192 | -6 | -0.5% | 833,300 |
2023/07/24 | 1,205 | 1,217 | 1,195 | 1,198 | -12 | -1% | 451,500 |
2023/07/21 | 1,200 | 1,219 | 1,189 | 1,210 | +21 | +1.8% | 565,000 |
2023/07/20 | 1,208 | 1,209 | 1,188 | 1,189 | -27 | -2.2% | 742,600 |
2023/07/19 | 1,211 | 1,223 | 1,201 | 1,216 | -1 | -0.1% | 808,500 |
2023/07/18 | 1,231 | 1,242 | 1,208 | 1,217 | +10 | +0.8% | 701,100 |
2023/07/14 | 1,240 | 1,257 | 1,203 | 1,207 | -25 | -2% | 827,700 |
2023/07/13 | 1,199 | 1,248 | 1,191 | 1,232 | +44 | +3.7% | 1,259,000 |
151~
200
件表示中 / 3451件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 243,100円 | +52.1% | +23.3% | 0.00% | 17.18倍 | 3.58倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
ネクセラファーマ | 157,000円 | +150.7% | - | 0.00% | 40.13倍 | 2.11倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 321,000円 | -1.2% | -37.3% | 2.49% | 25.86倍 | 0.90倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 182,700円 | +2.6% | +11.5% | 2.85% | 21.42倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
鳥居薬 | 408,000円 | +7.3% | +16.8% | 2.94% | 24.40倍 | 0.95倍 |
|
JT傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗HIV薬の販売権喪失が直撃 |
市場注目の銘柄
チャート関連のコラム